Diagnostic and therapeutic potential of tonic gamma-aminobutyric acid from reactive astrocytes in brain diseases

Keywords

astrocyte / MAO-B / putrescine / tonic GABA

References

[1] Koh W, Kwak H, Cheong E, Lee CJ. GABA tone regulation and its cognitive functions in the brain. Nat Rev Neurosci. 2023;24(9):523-539.

[2] Escartin C, Galea E, Lakatos A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312-325.

[3] Jo S, Yarishkin O, Hwang YJ, et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease. Nat Med. 2014;20(8):886-896.

[4] Ju YH, Bhalla M, Hyeon SJ, et al. Astrocytic urea cycle detoxifies A beta-derived ammonia while impairing memory in Alzheimer's disease. Cell Metab. 2022;34(8):1104-1120.e8.

[5] Park JH, Ju YH, Choi JW, et al. Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease. Sci Adv. 2019;5(3):eaav0316.

[6] Nam MH, Park JH, Song HJ, et al. KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson's Disease. Neurotherapeutics. 2021;18(3):1729-1747.

[7] Heo JY, Nam MH, Yoon HH, et al. Aberrant tonic inhibition of dopaminergic neuronal activity causes motor symptoms in animal models of Parkinson's Disease. Curr Biol. 2020;30(2):276-291.e9.

[8] Nam MH, Cho J, Kwon DH, et al. Excessive astrocytic GABA causes cortical hypometabolism and impedes functional recovery after subcortical stroke. Cell Rep. 2020;32(1):107861.

[9] Srivastava I, Vazquez-Juarez E, Henning L, Gomez-Galan M, Lindskog M. Blocking astrocytic GABA restores synaptic plasticity in prefrontal cortex of rat model of depression. Cells. 2020;9(7):1705.

[10] Sa M, Yoo ES, Koh W, et al. Hypothalamic GABRA5-positive neurons control obesity via astrocytic GABA. Nat Metab. 2023;5(9):1506-1525.

[11] Michels L, Schulte-Vels T, Schick M, et al. Prefrontal GABA and glutathione imbalance in posttraumatic stress disorder: preliminary findings. Psychiatry Res. 2014;224(3):288-295.

[12] Sakurai K, Nihashi T, Kimura Y, et al. Age-related increase of monoamine oxidase B in amyloid-negative cognitively unimpaired elderly subjects. Ann Nucl Med. 2022;36(8):777-784.

[13] Cheng YT, Woo J, Luna-Figueroa E, Maleki E, Harmanci AS, Deneen B. Social deprivation induces astrocytic TRPA1-GABA suppression of hippocampal circuits. Neuron. 2023;111(8):1301-1315 e5.

[14] Bortolato M, Shih JC. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol. 2011;100:13-42.

[15] Chun H, Im H, Kang YJ, et al. Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer's disease via H(2)O(2)(-) production. Nat Neurosci. 2020;23(12):1555-1566.

[16] Bhalla M, Lee CJ. Long-term inhibition of ODC1 in APP/PS1 mice rescues amyloid pathology and switches astrocytes from a reactive to active state. Mol Brain. 2024;17(1):3.

[17] Dyke K, Pepes SE, Chen C, et al. Comparing GABA-dependent physiological measures of inhibition with proton magnetic resonance spectroscopy measurement of GABA using ultra-high-field MRI. Neuroimage. 2017;152:360-370.

[18] Liu Y, Jiang H, Qin X, Tian M, Zhang H. PET imaging of reactive astrocytes in neurological disorders. Eur J Nucl Med Mol Imaging. 2022;49(4):1275-1287.

[19] Harada R, Furumoto S, Kudo Y, Yanai K, Villemagne VL, Okamura N. Imaging of reactive astrogliosis by positron emission tomography. Front Neurosci. 2022;16:807435.

[20] Nam MH, Ko HY, Kim D, et al. Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG. Brain. 2023;146(7):2957-2974.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.